- Home
- BRX vs EXAS Comparison
BRX vs EXAS Comparison
Compare BRX & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRX
- EXAS
- Stock Information
- Founded
- BRX 2011
- EXAS 1995
- Country
- BRX United States
- EXAS United States
- Employees
- BRX N/A
- EXAS N/A
- Industry
- BRX Real Estate Investment Trusts
- EXAS Medical Specialities
- Sector
- BRX Real Estate
- EXAS Health Care
- Exchange
- BRX Nasdaq
- EXAS Nasdaq
- Market Cap
- BRX 8.6B
- EXAS 10.2B
- IPO Year
- BRX 2013
- EXAS N/A
- Fundamental
- Price
- BRX $27.99
- EXAS $53.94
- Analyst Decision
- BRX Buy
- EXAS Strong Buy
- Analyst Count
- BRX 13
- EXAS 22
- Target Price
- BRX $30.23
- EXAS $67.38
- AVG Volume (30 Days)
- BRX 1.9M
- EXAS 2.9M
- Earning Date
- BRX 10-27-2025
- EXAS 11-04-2025
- Dividend Yield
- BRX 4.10%
- EXAS N/A
- EPS Growth
- BRX 12.30
- EXAS N/A
- EPS
- BRX 1.09
- EXAS N/A
- Revenue
- BRX $1,326,128,000.00
- EXAS $2,939,949,000.00
- Revenue This Year
- BRX $6.22
- EXAS $16.50
- Revenue Next Year
- BRX $3.74
- EXAS $12.32
- P/E Ratio
- BRX $25.76
- EXAS N/A
- Revenue Growth
- BRX 5.27
- EXAS 12.55
- 52 Week Low
- BRX $22.29
- EXAS $38.81
- 52 Week High
- BRX $30.67
- EXAS $72.83
- Technical
- Relative Strength Index (RSI)
- BRX 59.88
- EXAS 63.63
- Support Level
- BRX $27.56
- EXAS $46.30
- Resistance Level
- BRX $28.47
- EXAS $56.52
- Average True Range (ATR)
- BRX 0.40
- EXAS 1.67
- MACD
- BRX -0.04
- EXAS 0.91
- Stochastic Oscillator
- BRX 60.98
- EXAS 76.84
About BRX Brixmor Property Group Inc.
Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.